Clinical Trial Update: Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness [Phase 2]

View source ↗

Summary

A Phase 2 CDC-sponsored trial evaluating rifampin in combination with azithromycin for Onchocerciasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onchocerciasis

Drugs mentioned

• Azithromycin (azithromycin)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Onchocerciasis | Phase 2 | Status: COMPLETED